已收盤 01-09 16:00:00 美东时间
+0.140
+0.45%
临床阶段生物制药公司Praxis Precision Medicines(PRXV)周一盘前上涨逾2%,此前BTIG将其股票列为2026年首选标的,并上调了...
2025-12-29 21:50
Praxis Investment Management launches 2 ETFs targeting growth & value with faith-based screens, appealing to investor values & demand for performance.
2025-04-10 02:25